Roper Technologies (ROP) to Divest CIVCO Radiotherapy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Roper Technologies to Divest CIVCO Radiotherapy
October 22, 2021 6:55 AM EDTSARASOTA, Fla., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (NYSE: ROP), a leading diversified technology company, today announced that it has reached a definitive agreement to sell its CIVCO Radiotherapy business to an affiliate of Blue Wolf Capital Partners LLC, a private equity firm, in an all-cash transaction valued at $120 million. Roper will retain its CIVCO Medical Solutions business, which will continue to operate independently.
Roper retained William Blair as a financial advisor in connection with this transaction. Roper expects the transaction to close in the fourth quarter, subject to... More
